As of 11:39am ET
| +0.48 / +0.31%|
The 8 analysts offering 12-month price forecasts for Abiomed Inc have a median target of 162.50, with a high estimate of 180.00 and a low estimate of 147.00. The median estimate represents a +4.41% increase from the last price of 155.64.
The current consensus among 10 polled investment analysts is to Buy stock in Abiomed Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.